say? and the industry a great everyone. I What afternoon, Curaleaf Boris, It cannabis can whole. for was you, a and Thank quarter good as
that extremely quarter is also happy commercialization the to definitive in we're advances development. working. our We incredibly about product are I'm and our with as and excited continuing research strategy significant for it make the is record proof results
more pillars continue to competitive some on detail of in and of the of most these initiatives capabilities provide will are Our one areas exciting unmatched in later the I'll industry our call. as in long-term our advantage. act
my Let retail at walk-through level. the me start
U.S. selectively footprint. continue expanding our We market-leading
Maine, location July opening adult-use and next today. in in We on followed quarter XXX quantity another X we dispensary the new of bringing dispensaries Illinois, on we X the As in second our premium XXrd, as X store continue total including to Pennsylvania, phase right in adding and over quality of the Maine stores our U.S. move into retail Jersey, New first by in flagship expansion, locations. focus count and opened Wells, only in to are in our
to Pennsylvania. During open dispensaries the expect across we Curaleaf and an Jersey, New remainder retail Florida, of additional X Arizona, XXXX, new
and have build a this share XX dispensaries store total we plan and in gained this of in to Florida We of by have market XXXX. on new the state with to steadily end openings expect
we as mentioned patients, our process but in past, the welcoming well which are reflect adult-use believe dispensaries a relevant is we've of more contemporary to As as to our in the rebranding medical legacy consumers. of also we look, all
complete We rebranding by end September. of the be the to expect
Our on positive, Including XX% medical was use, up revenue side operating the with second-quarter retail number transactions of financial total sequentially. and adult-use the second the were very during growing retail metrics quarter. both and XX%
second the business, grow, the wholesale X,XXX At On expanding level, March, helped to of X% wholesale number U.S. of during XX%. which patients quarter while number total X% side of by drive grew order month of we the the accounts sequential value. revenue of by the from during the June continues accounts, average surpass medical active to approximately growth maintaining the
competitive distribution is Our pillars of of wholesale another advantage. sustainable platform our
As we to a widest the CPG-focused believe continue array invest to we the continue in that of brands consumers. in reaches and a power Cannabis portfolio of Company,
quarter, Noble demographics. Curaleaf Stones and the launched Maryland, Select relationships and we and drive introduced leveraging partnerships Massachusetts visibility This Rolling and strategic partnership preference in Select and we in Nevada the new B brand to to
capacity, new harvesting Florida, cultivation we Pennsylvania, cultivation centers of Arizona, terms In Jersey. New in Maine, our from and began
brought expansion canopy these of square half of online of of expansions, XXX,XXX expected first nearly now year. feet annual flower the feet have With our square the we during XXX,XXX
as capacity will Operating square the of the additional commission in but half. margins catalyst not half additional for help in a to feet accelerated improve also XX,XXX an our expect the We serve growth second This only will year. second
the York, We New states, additional are key also commissioned of and will in be of Pennsylvania. that New process in building XXXX number Jersey, Florida, Connecticut, including a capacity in
We are the excited year. about our the balance of prospects for
our site store in For growth. help And cultivation to dispensary full wholesale In our we the will Massachusetts, state. market our state. business in half of superior second new in continue Xrd should continued Maryland, ramp wholesale we're this to site open imminently, quarter example, will from processing the by dispensaries share expansion locations that our in to in new the year. of the process drive expect up larger In gaining continue cultivation openings of will in driven moving of a our Jersey, business cultivation benefit we Florida, our and the New and expect and and a
and commercialization have a underway. we product and initiatives onto development, exciting of Moving number research
we in bring roll investors, testing out expect we of As final said new the our previous to which calls stages proprietary in extraction XXXX. early are down cost which technology, to of should in our production, pilot we substantially
along Gummy Classic way the over improved experience. we the and including they proprietary to Nano flavors nanotechnology, Squeeze line. new faster-acting to bring our fresh launch even will choice to than their variety enjoy which quarter This consumers our line, innovation is the technology continue to and provide the Gummy our Also, to with nanotechnology, we utilizing current control innovative latest ultimate add
on exploring multiple and innovation also developing CBN, and the through such cannabinoids, of clinical other potential delivery formulations benefits been working have We CBG technologies and studies. unique THCV, as
bring We of these incorporate market expect half XXXX. cannabinoids to the products that to in second
In and across products addition, categories and new products XXX little in we improving fill that many innovation. Squeeze vape, think develop where we actively market. the beverage, our of ready-to-drink over was launched I and innovation assortment concentrate, the the proprietary Little developing i. our XXXX. terms big we little of forth. our products out within to past When months. of so think innovative bring topical over launched packaging I, innovation, a will were We've of are footprint, a we which of be majority first new big texture, technology and XX to portfolio am product flavor, The to oral, example
have our we new provide research that factors form over of months. exciting technologies new ramped is next innovation full and the funnel of and development XX will stream Now products up that capabilities steady a our
demand. European In growth to small our our we United cannabis on operation, important significant still in strain while Moving second a making revenue, to flower continues Kingdom, patient contributor the International, medical Curaleaf launched of meet to the strides.
We pharma Spain product in flower received now in and with cannabis witnessed a for alchemy of GMP cannabis increase partnership Germany. cannabis Spain, in purposes. strategic in announced flowers. It distribute a of certification clinics. investigational cannabis year. throughout EU pharmaceutical leader patient this additional in processing have Uvigo, treatment we called XXX% a and Company by can was product distributed lab our entered Also, manufactured in the paying of recently March In medical the first disease. product by co-branded launch since numbers in and medical the our specialized of Curaleaf Germany into commercialization Zambon, June, Parkinson's adopted International UK a We medical a The launched X the for products and medical manufacture as
under further sold and Only been very new out end the currently exported we second regulation. and to tons flowers product being of to Europe, is each Company Beyond does X.X month. so by track The medical on Cannabis has Israel of Israel. the received adding has is the X,XXX patients a well August. over XXX,XXX
do important the and Finally, with moving Portugal CBD of Cannabis forward we're the responsibility. initiatives the French like with quarter suppliers, adult-use to discussion business some XX Court the and processes other legalization their a legality and partners. ended things on with are with the We I'd around possible and Spain advocacy Malta our doing on of France. in as to forward Supreme close social updates Cannabis. moving communities. products medical matters industry brands, gave important underrepresented establishing the from program is very ciliary the judgment organizations In leader in political with Wellness respective of Cannabis
by we opportunities In B directly the impacted funding Noble our of dedicated and providing Maryland drugs. in to to in equity addition, on social Massachusetts July advancing with sales pre-rolls and to dedicated those a local launched organizations, portion war
evaluate that female-funded force On Greentech to the Curaleaf carbon task we environmental carbon an to audit of assembled a the becoming has I'm neutral. complete startup have And pleased footprint. share strategies front, hired for our to Map-Collective,
call over Now, Ranjan. let the to me turn